Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search
  1. Home
  2. Publications & data
Filter by
  • Filter by
  • Remove this filter Infectious disease: Respiratory diseases
  • Remove this filter Type: Publication
  • Remove this filter Public health topic: Public health threat
  • Remove this filter Public health topic: Threats and outbreaks
  • Remove this filter Public health topic: Surveillance
  • Infectious disease
    • Respiratory diseases (80)
    • Vaccine preventable diseases (77)
    • Influenza (57)
    • Mosquito-borne diseases (39)
    • Viral haemorrhagic fever (29)
    • Ebola haemorrhagic fever (29)
    • Poliomyelitis (28)
    • Middle East respiratory syndrome coronavirus (28)
    • Zoonosis (24)
    • Food- and waterborne diseases (22)
    • Chikungunya virus disease (18)
    • Coronavirus (18)
    • Dengue (17)
    • COVID-19 (17)
    • SARS-CoV-2 (17)
    • Zika virus disease (16)
    • Measles (15)
    • West Nile virus infection (13)
    • Avian influenza virus (13)
    • Zoonotic influenza (13)
    • Legionnaires’ disease (9)
    • Tuberculosis (8)
    • Viral hepatitis (8)
    • Cholera (7)
    • Rubella (7)
    • Yellow fever (7)
    • Hepatitis A (7)
    • Influenza in humans, seasonal (7)
    • Influenza in humans, avian origin (7)
    • German measles (7)
    • Seasonal influenza (7)
    • Flu (7)
    • Ebola outbreak - North Kivu, DRC (6)
    • Salmonellosis (5)
    • Influenza in humans, swine origin (5)
    • Healthcare-associated infections (4)
    • Influenza A (H1N1) (4)
    • Nosocomial infections (3)
    • Enterovirus (3)
    • Influenza A (H1N1)2009 (3)
    • Pneumococcal disease (3)
    • Infections in long-term care facilities (3)
    • Coxsackievirus (3)
    • Invasive pneumococcal disease (3)
    • S. pneumoniae (3)
    • Vibrio (3)
    • Avian influenza in humans (3)
    • Influenza A (H9N2) (3)
    • Streptococcus pneumoniae (3)
    • HIV infection (2)
    • Botulism (2)
    • Sexually transmitted infections (2)
    • Emerging disease (2)
    • Acquired immunodeficiency syndrome (AIDS) (2)
    • Human immunodeficiency virus infection (2)
    • Zika virus disease - Outbreak in the Americas (2)
    • Multidrug-resistant tuberculosis (2)
    • Q fever (1)
    • Toxoplasmosis, congenital (1)
    • Malaria (1)
    • Echinococcosis (1)
    • Trichinellosis (1)
    • Diphtheria (1)
    • Yersiniosis (1)
    • Campylobacteriosis (1)
    • Pertussis (1)
    • Listeriosis (1)
    • Anthrax (1)
    • Escherichia coli infection (1)
    • Rabies (1)
    • Hantavirus infection (1)
    • Influenza in humans, pandemic (1)
    • Tularaemia (1)
    • Marburg haemorrhagic fever (1)
    • Louse-borne diseases (1)
    • Klebsiella pneumoniae (1)
    • Influenza A(H5N6) (1)
    • Influenza A(H5N8) virus (1)
    • Marburg virus diseases (1)
    • Hepatitis (1)
    • Haemorrhagic fever with renal syndrome (Puumala caused) (1)
    • Enterohaemorrhagic Escherichia coli (EHEC) infection (1)
    • Hydatidosis (1)
    • Whooping cough (1)
    • Nephropathia epidemica (1)
    • Ebola outbreak - Guinea (1)
  • Public health area
    • Public health threat (80)
    • Surveillance (80)
    • Threats and outbreaks (80)
    • Outbreak (80)
    • Prevention and control (12)
    • Disease prevention (12)
    • Prophylaxis (12)
    • Epidemiology (9)
    • Laboratories (7)
    • Microbiology (5)
    • Antimicrobial resistance (4)
    • Scientific advice (4)
    • Control campaign (4)
    • Public health response (4)
    • Antibiotic resistance (4)
    • Epidemic (3)
    • Preparedness (3)
    • Mass gathering (3)
    • Pandemic preparedness (2)
    • Vaccination (2)
    • Laboratory based surveillance (2)
    • Laboratory capacity (2)
    • Active immunisation (2)
    • Immunisation (2)
    • Whole genome sequencing (2)
    • High-risk groups (2)
    • Country cooperation (1)
    • Epidemic intelligence (1)
    • Health communication (1)
    • Laboratory quality (1)
    • Molecular typing (1)
    • Reference laboratory (1)
    • Risk communication (1)
    • Case management (1)
    • Multidrug resistance (1)
    • Hospital infection control (1)
    • Diagnostic test (1)
    • Crisis communication (1)
  • Publication series
    • Communicable Disease Threats Report (CDTR) (42)
    • Avian influenza overview (2)
    • The European Union One Health Zoonoses Report (1)
  • Country
    • Europe (60)
    • Asia (27)
    • Africa (20)
    • Americas (12)
    • North America (1)
    • Pacific regions (1)
  • Media type
    • Publication (80)
    • Surveillance report (41)
    • Peer-reviewed publication (23)
    • Data (12)
    • Risk assessment (6)
    • Infographic (6)
    • Technical report (5)
    • Technical guidance (1)
  • All (92)
  • Publication (80)
  • Data (12)
  • Page 1 of 8 // 80 Results found
    • Sort by:

Publication

Communicable disease threats report, 21-27 February 2021, week 8

Publication - 26 Feb 2021

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 February 2021 and includes updates on COVID-19, Avian influenza A(H5N8) virus, seasonal influenza, Ebola virus disease, chikungunya virus disease and dengue.

Communicable disease threats report, 21-27 February 2021, week 8 - EN - [PDF-2.32 MB]
  • Avian influenza virus
  • Chikungunya virus disease
  • Dengue
  • Ebola haemorrhagic fever
  • Ebola outbreak - Guinea
  • Ebola outbreak - North Kivu, Ituri, DRC
  • EU/EEA
  • Influenza in humans, avian origin
  • Influenza in humans, seasonal
  • Public health threat
  • Surveillance

Publication

European surveillance of COVID-19 in long-term care facilities in the EU/EEA: aggregate data reporting - Surveillance protocol version 1.1

Technical report - 12 Feb 2021

This surveillance protocol seeks to enable countries to report their existing national surveillance data on COVID-19 in LTCFs easily and regularly. This will enable ECDC to report national trends in the EU/EEA, with the aim of providing all EU/EEA countries with timely information to support their preparedness activities for LTCFs.

European surveillance of COVID-19 in long-term care facilities in the EU/EEA: aggregate data reporting - EN - [PDF-442.67 KB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Healthcare-associated infections
  • Infections in long-term care facilities
  • Public health threat
  • Surveillance

Publication

Risk Assessment: Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update

Risk assessment - 21 Jan 2021

This risk assessment presents the latest available information on the recent emergence of three variants of concern, VOC 202012/01 identified in the United Kingdom (UK), 501Y.V2 identified in South Africa, and P.1 identified in Brazil and Japan.

Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update - EN - [PDF-1.46 MB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Public health threat
  • Surveillance

Publication

Sequencing of SARS-CoV-2 - first update

Technical guidance - 18 Jan 2021

This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on which technologies to use and/or in deciding on the role of sequencing for SARS-CoV-2 diagnostics, research, outbreak investigations and surveillance.

Sequencing of SARS-CoV-2 - first update, 18 January 2021 - EN - [PDF-592 KB]
  • Coronavirus
  • COVID-19
  • Diagnostic test
  • EU/EEA
  • Laboratories
  • Laboratory based surveillance
  • Microbiology
  • Molecular typing
  • Public health threat
  • Surveillance
  • Whole genome sequencing

Publication

ECDC rapid assessment of laboratory practices and needs related to COVID-19

Technical report - 18 Jan 2021

This report assesses the current status of the EU/EEA and the UK COVID-19 laboratory response based on a short survey sent to all Member States and the UK.

ECDC rapid assessment of laboratory practices and needs related to COVID-19 - EN - [PDF-400.12 KB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Laboratories
  • Laboratory capacity
  • Microbiology
  • Public health threat
  • Surveillance

Peer-Reviewed Publication

Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020

Jan 2021 - Euro Surveill - 26(2)

S. K. Nørgaard, L. S. Vestergaard, J. Nielsen, L. Richter, D. Schmid, N. Bustos, T. Braye, M. Athanasiadou, T. Lytras, G. Denissov, T. Veideman, O. Luomala, T. Möttönen, A. Fouillet, C. Caserio-Schönemann, M. An der Heiden, H. Uphoff, K. Gkolfinopoulou, J. Bobvos, A. Paldy, N. Rotem, I. Kornilenko, L. Domegan, J. O'Donnell, F. Donato, M. Scortichini, P. Hoffmann, T. Velez, K. England, N. Calleja, L. van Asten, L. Stoeldraijer, R. A. White, T. H. Paulsen, S. P. da Silva, A. P. Rodrigues, P. Klepac, M. Zaletel, M. Fafangel, A. Larrauri, I. León, A. Farah, I. Galanis, C. Junker, D. Perisa, M. Sinnathamby, N. Andrews, M. G. O'Doherty, D. Irwin, S. Kennedy, J. McMenamin, C. Adlhoch, N. Bundle, P. Penttinen, J. Pukkila, R. Pebody, T. G. Krause and K. Mølbak

  • Coronavirus
  • COVID-19
  • Europe
  • Influenza
  • Prevention and control
  • Public health threat
  • Surveillance

Peer-Reviewed Publication

Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017-2019: an ECDC pilot study

Jan 2021 - Eur Respir J - 57(1):2002272

E. Tagliani, R. Anthony, T. A. Kohl, A. de Neeling, V. Nikolayevskyy, C. Ködmön, F. P. Maurer, S. Niemann, D. van Soolingen, M. J. van der Werf and D. M. Cirillo

  • Europe
  • Multidrug-resistant tuberculosis
  • Prevention and control
  • Public health threat
  • Reference laboratory
  • Surveillance
  • Tuberculosis
  • Whole genome sequencing

Publication

Risk Assessment: Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA

Risk assessment - 29 Dec 2020

This risk assessment presents the latest available information on the recent emergence of two variants of potential concern, VOC 202012/01 discovered in the United Kingdom (UK) and another variant, 501.V2 identified in South Africa. It also assesses the risk of these variants of concern being introduced and spread in the EU/EEA, as well as the increased impact this would have on health systems in the coming weeks.

Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA - EN - [PDF-1.31 MB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Public health threat
  • Surveillance

Publication

Threat Assessment Brief: Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom

Risk assessment - 20 Dec 2020

Over the last few weeks, the United Kingdom (UK) has faced a rapid increase in COVID-19 cases in South East England, leading to enhanced epidemiological and virological investigations.

Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom - EN - [PDF-647.35 KB]
  • Coronavirus
  • COVID-19
  • Public health threat
  • Surveillance

Publication

Avian influenza overview – update on 19 November 2020, EU/EEA and the UK

Surveillance report - 20 Nov 2020

Since 16 October 2020, outbreaks of highly pathogenic avian influenza (HPAI) viruses have been reported in several EU/EEA countries – Belgium, Denmark, France, Germany, Ireland, the Netherlands, and Sweden as well as in the United Kingdom.

Avian influenza overview – update on 19 November 2020, EU/EEA and the UK - EN - [PDF-1.19 MB]
  • Avian influenza virus
  • Influenza
  • Influenza A(H5N8) virus
  • Influenza in humans, avian origin
  • Public health threat
  • Surveillance

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us